Post-transplant cyclophosphamide versus antithymocyte globulin in patients with acute myeloid leukemia in first complete remission undergoing allogeneic stem cell transplantation from 10/10 HLA-matched unrelated donors - Archive ouverte HAL Access content directly
Journal Articles Journal of Hematology and Oncology Year : 2020

Post-transplant cyclophosphamide versus antithymocyte globulin in patients with acute myeloid leukemia in first complete remission undergoing allogeneic stem cell transplantation from 10/10 HLA-matched unrelated donors

, , , , , , , , , (1) , , , , , , , , , , , , ,
1
Eolia Brissot
  • Function : Author
Myriam Labopin
Ian Moiseev
  • Function : Author
J. Cornelissen
  • Function : Author
Ellen Meijer
  • Function : Author
Gwendolyn van Gorkom
  • Function : Author
Montserrat Rovira
  • Function : Author
Fabio Ciceri
Laimonas Griskevicius
  • Function : Author
Edouard Forcade
Martin Mistrik
  • Function : Author
Stephan Mielke
Claude Eric Bulabois
  • Function : Author
Riitta Niittyvuopio
  • Function : Author
Eric Deconinck
Annalisa Ruggeri
Jaime Sanz
Alexandros Spyridonidis
Bipin Savani
Sebastian Giebel
Arnon Nagler
Mohamad Mohty

Dates and versions

hal-03152863 , version 1 (25-02-2021)

Identifiers

Cite

Eolia Brissot, Myriam Labopin, Ian Moiseev, J. Cornelissen, Ellen Meijer, et al.. Post-transplant cyclophosphamide versus antithymocyte globulin in patients with acute myeloid leukemia in first complete remission undergoing allogeneic stem cell transplantation from 10/10 HLA-matched unrelated donors. Journal of Hematology and Oncology, 2020, 13 (1), ⟨10.1186/s13045-020-00923-0⟩. ⟨hal-03152863⟩

Collections

CNRS UNIV-AMU CRCM
27 View
0 Download

Altmetric

Share

Gmail Facebook Twitter LinkedIn More